Cart
sales@molnova.com
VAS2870
CAS No. 722456-31-7
VAS2870( VAS 2870 )
Catalog No. M17580 CAS No. 722456-31-7
VAS2870 is a NADPH oxidase (NOX) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 55 | In Stock |
|
| 5MG | 49 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 180 | In Stock |
|
| 50MG | 321 | In Stock |
|
| 100MG | 480 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVAS2870
-
NoteResearch use only, not for human use.
-
Brief DescriptionVAS2870 is a NADPH oxidase (NOX) inhibitor.
-
DescriptionVAS 2870 is a NADPH oxidase (Nox) inhibitor that enhances TGF-β-induced apoptosis of liver tumor cells.
-
In Vitro——
-
In Vivo——
-
SynonymsVAS 2870
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorNADPH oxidase (NOX)
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number722456-31-7
-
Formula Weight360.4
-
Molecular FormulaC18H12N6OS
-
Purity>98% (HPLC)
-
SolubilityDMSO : 83.3 mg/mL. 231.14 mM;
-
SMILESC12=C(SC3=NC4=C(C=CC=C4)O3)N=CN=C1N(CC5=CC=CC=C5)N=N2
-
Chemical Name7-(2-Benzoxazolylthio)-3-(phenylmethyl)-3H-1,2,3-triazolo[4,5-d]pyrimidine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.ten Freyhaus H, et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res. 2006 Jul 15;71(2):331-41.
molnova catalog
related products
-
BIP-135
BIP-135 is a potent and selective ATP-competitive GSK-3 inhibitor. With IC50s of 16 nM and 21 nM for GSK-3α and GSK-3β, respectively. BIP 135 exhibits neuroprotective effect.
-
BIO
A cell-permeable derivative of 6-bromoindirubin that displays selective inhibition of GSK-3 with IC50 of 5 nM.
-
VP3.15 dihydrobromid...
VP3.15 dihydrobromide is a potent orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM 0.88 μMrespectively.)
